Towards heat-stable oxytocin formulations: analysis of degradation kinetics and identification of degradation products.
about
Pulmonary delivery of an ultra-fine oxytocin dry powder formulation: potential for treatment of postpartum haemorrhage in developing countriesCapillary electrophoresis separation of the desamino degradation products of oxytocinCapillary electrophoresis-mass spectrometry using noncovalently coated capillaries for the analysis of biopharmaceuticals.A new strategy to stabilize oxytocin in aqueous solutions: I. The effects of divalent metal ions and citrate buffer.Heat-Stable Dry Powder Oxytocin Formulations for Delivery by Oral InhalationConverting disulfide bridges in native peptides to stable methylene thioacetals.Non-Arrhenius protein aggregation.Oxidation of therapeutic proteins and peptides: structural and biological consequences.Physicochemical and formulation developability assessment for therapeutic peptide delivery--a primerCharacterization of recombinant human IL-15 deamidation and its practical elimination through substitution of asparagine 77.On the mechanism of degradation of oxytocin and its analogues in aqueous solution.The impact of thermal stability of oxytocin on access, and the importance of setting proper product specifications.Development and stability of a heat-stable formulation of carbetocin for the prevention of postpartum haemorrhage for use in low and middle-income countries.Selenoether oxytocin analogues have analgesic properties in a mouse model of chronic abdominal painQuality of oxytocin ampoules available in health care facilities in the Democratic Republic of Congo: an exploratory study in five provincesModeling patient access to therapeutic oxytocin in Zanzibar, Tanzania
P2860
Q28537941-5940EE49-1599-4D28-BB91-E987204F0568Q33785542-26BD4D16-7A19-4A4E-8895-27B0E30493F0Q34705552-879D0592-F985-4ADF-B30F-9DEAA5D5CD0BQ34901001-58E9D0DF-0F05-4BB8-9F82-1B70CE46E93BQ35578871-E16DCEBE-F87A-4AA6-8B1B-136A51C21402Q37707861-38001B09-95AB-4CC0-81F2-B85E2A70619BQ38101467-84A6B9DF-9A97-4CA8-9492-D9F2A88D329DQ38142887-91DFA2C7-479C-4D5A-BF45-A5ABA4BD688CQ38268308-07A55DFA-BE68-4140-B793-C37A410639D5Q39456212-4F7698AD-8D5E-4D26-A930-C5F88B3934B7Q44257013-BC10D6BA-E334-4A22-AB26-7E248A6570BBQ50259121-4D6D07C1-B633-4A30-AA91-AC4635F94994Q55189143-F8299B58-6EFE-4023-B9A9-DAA229D7A750Q58284514-243EA4CE-8222-461A-BCF7-DABCEFCCF36FQ58762185-1B6FF7AE-8C27-48F5-9C15-27593421E02EQ58770685-3405D3C0-2479-4302-B735-5E1864B68F9D
P2860
Towards heat-stable oxytocin formulations: analysis of degradation kinetics and identification of degradation products.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Towards heat-stable oxytocin f ...... ation of degradation products.
@en
Towards heat-stable oxytocin f ...... ation of degradation products.
@nl
type
label
Towards heat-stable oxytocin f ...... ation of degradation products.
@en
Towards heat-stable oxytocin f ...... ation of degradation products.
@nl
prefLabel
Towards heat-stable oxytocin f ...... ation of degradation products.
@en
Towards heat-stable oxytocin f ...... ation of degradation products.
@nl
P2093
P2860
P1476
Towards heat-stable oxytocin f ...... ation of degradation products.
@en
P2093
Andrea Hawe
Piotr Kasper
Rob van der Heijden
Robert Poole
Stefan Romeijn
Wim Jiskoot
P2860
P304
P356
10.1007/S11095-009-9878-2
P577
2009-04-03T00:00:00Z